CAD4TB: Artificial Iintelligence for Tuberculosis Detection Globally

ThironaIs it possible to screen thousands of people for tuberculosis using artificial intelligence in a country where internet barely exists? It is with CAD4TB. As of October, this innovative software is used to screen people for TB in even the remotest areas of Eritrea. It has been developed by Dutch company Thirona in collaboration with the also Dutch Delft Imaging Systems. CAD4TB is the most validated and widely used artificial intelligence solution for TB-detection worldwide. Every day, it is used to screen 7.000 people for this disease that kills 1.6 million people a year - that is more than die from AIDS and malaria combined.

TB tracked down

The Eritrean Ministry of Health gives high priority to the elimination of deadly diseases, but the local infrastructure is largely underdeveloped and internet is scarcely available. It makes TB-screening challenging and time-consuming. Computer-Aided Detection for Tuberculosis (CAD4TB) is a software programme that analyses digital chest x-rays. In situations with a working internet connection, the chest image is analysed by the CAD4TB server in the cloud. In places where an internet connection is not available or not reliable, images can be analysed directly on-site. With this portable solution, TB can be tracked down and treated anywhere.

Virtual doctor

Guido Geerts, CEO of Thirona, about the necessity of implementing artificial intelligence in combating TB in Eritrea: "In Eritrea, only 1% of the population has access to the internet, radiologists are scarce and large parts of the country are extremely difficult to reach. The big advantage of CAD4TB is the option to use it completely offline, so we can professionally screen people even in the most remote areas. Within twenty seconds the x-ray image is analysed and the likelihood of someone having TB determined. It is a virtual doctor that has scientifically been proven to be more accurate than an expert human reader."

For further information, please visit:
http://www.thirona.eu

About Thirona

Thirona is an innovative Dutch company specialised in artificial intelligence for medical image analysis. By creating intuitive and user-friendly products, it bridges the gap between academic ideas and clinical use. Thirona supports medical professionals in their daily tasks working with thoracic CT-scans (LungQ), chest x-rays (CAD4TB) and retinal scans (RetCAD). Thirona was established in 2014 and has grown out to be an important player in the medical field with innovative AI-solutions used in over forty countries worldwide.

Most Popular Now

Researchers Capture First Images of Oxyg…

Oxygen in cancer tumors is known to be a major factor that helps radiation therapy be successful. Hypoxia, or starvation of oxygen, in solid tumors is also thought to be...

VTT Makes New Investments in Digital Hea…

VTT is launching new research activities in the area of digital health as part of the growing wellbeing and health technology ecosystem in Kuopio. The new initiative aims to create...

A New Method of Artificial Intelligence …

Despite the immense progress in the field of AI in recent years, we are still very far from human intelligence. Indeed, if current AI techniques allow to train computer agents...

FDA Informs Health Care Providers, Facil…

Today, the U.S. Food and Drug Administration is issuing a safety communication informing health care providers, facilities and patients about cybersecurity vulnerabilities identified for certain GE Healthcare Clinical Information Central...

eHealthWeek 2020 Croatia - Trusted Infor…

15 - 17 April 2020, Rovinj, Croatia. In its capacity of hosting the upcoming Presidency of the Council of the European Union, the Croatian Ministry of Health is in preparations to...

Siemens Healthineers Presents Solutions …

CT scanners with intelligent user guidance, AI-based software assistants for MRI and a lab system that revolutionizes workflows: Siemens Healthineers is showcasing its products and solutions according to the motto...

NHS IT Chiefs Set the Stage for a Year o…

3 - 4 March 2019, London, United Kingdom. NHS technology leaders are to kick off the second-ever Digital Health Rewired Conference and Exhibition on 3 - 4 March at the Olympia...

PatchAi Startup has Arrived in the Marke…

PatchAi - a startup that offers, thanks to Artificial Intelligence and Machine Learning, an empathic virtual assistant to patients participating in clinical trials - announced that it has closed two...

Digital Health App Medicus AI Earns CE C…

Medicus AI, the Vienna-based health tech company, has received a ​Class I Medical Device CE Mark for its mobile application. The CE certification mark confirms that Medicus AI conforms to...

FDA Authorizes Marketing of First Cardia…

Today, the U.S. Food and Drug Administration authorized marketing of software to assist medical professionals in the acquisition of cardiac ultrasound, or echocardiography, images. The software, called Caption Guidance, is...

Human Body-on-Chip Platform Enables In V…

Drug development is an extremely arduous and costly process, and failure rates in clinical trials that test new drugs for their safety and efficacy in humans remain very high. According...

AI in Drug Discovery Conference 2020

16 - 17 March 2020, London, UK. SMi group presents the launch of the inaugural AI in Drug Discovery conference taking place in London. AI-empowered machine learning technologies hold the potential...